Total Funding
89
49
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9339
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
- Steve Swann: Chief Scientific OfficerPast Role: Exscientia, Vice President Medicinal Chemistry (US)
- Alessandro Monge: Chief Business OfficerPast Role: Iktos, Senior Vice President, Head of US Operations and Business Development
About the Company
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
